SPC530

Samsetning af (a) vanzacaftor eða lyfjafræðilega viðunandi salti þar af, ákjósanlega kalsíumsalti þar af, (b) tezacaftor eða lyfjafræðilega viðunandi salti þar af, og (c) deutivacaftor eða lyfjafræðilega viðunandi salti þar af / A combination of (a) vanzacaftor or a pharmaceutically acceptable salt thereof, preferably a calcium salt thereof, (b) tezacaftor or a pharmaceutically acceptable salt thereof, and (c) deutivacaftor or a pharmaceutically acceptable salt thereof

  • Status:
    Umsókn
  • Application date:
    2.12.2025
  • Application published:
    14.1.2026
  • Medicine name:
    Alyftrek
  • Medicine for children:
    No

Timeline

Today
2.12.2025Application
14.1.2026Publication

Marketing license

    • Foreign authorization number:
      EU/1/25/1943
    • Date:
      30.6.2025

    Owner

    • Name:
      Vertex Pharmaceuticals Incorporated
    • Address:
      50 Northern Avenue, Boston, MA 02210 US

    Agent

    • Name:
      Árnason Faktor ehf.
    • Address:
      Guðríðarstíg 2-4, 113 Reykjavík

    Patent

    Upload documents